Close
  Indian J Med Microbiol
 

Figure 1: Distribution of selected clinical and virologic factors between chronic hepatitis B carriers and patients with hepatocellular carcinoma. Odds ratio favoring the development of HCC was 2.8 (95% confidence interval: 1.7-4.6, P<0.001) for male gender compared with female gender, 2.1 (95% confidence interval: 1.2-3.4, P=0.005) for genotype C compared with genotype B; and 19.7 (95% confidence interval: 11.3-34.1, P<0.001) for basal core promoter T1762/A1764 compared with A1762/G1764.

Figure 1: Distribution of selected clinical and virologic factors between chronic hepatitis B carriers and patients with hepatocellular carcinoma. Odds ratio favoring the development of HCC was 2.8 (95% confidence interval: 1.7-4.6, P<0.001) for male gender compared with female gender, 2.1 (95% confidence interval: 1.2-3.4, P=0.005) for genotype C compared with genotype B; and 19.7 (95% confidence interval: 11.3-34.1, P<0.001) for basal core promoter T1762/A1764 compared with A1762/G1764.